nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Indacaterol—asthma	0.423	1	CbGbCtD
Raltegravir—CCR1—respiratory system—asthma	0.00711	0.345	CbGeAlD
Raltegravir—CCR1—cardiovascular system—asthma	0.00545	0.264	CbGeAlD
Raltegravir—CCR1—adrenal gland—asthma	0.00431	0.209	CbGeAlD
Raltegravir—CCR1—lung—asthma	0.00378	0.183	CbGeAlD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.000456	0.002	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—EDNRB—asthma	0.000456	0.00199	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CSF2RB—asthma	0.000453	0.00198	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—TAC1—asthma	0.000451	0.00197	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—NPS—asthma	0.000451	0.00197	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—C3—asthma	0.000447	0.00196	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—TACR2—asthma	0.000444	0.00194	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR8—asthma	0.000444	0.00194	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CXCR3—asthma	0.000442	0.00194	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.000425	0.00186	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—POMC—asthma	0.000424	0.00186	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PTGDR2—asthma	0.00042	0.00184	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HRH4—asthma	0.00042	0.00184	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—NPSR1—asthma	0.00042	0.00184	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PMCH—asthma	0.00042	0.00184	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—CCL2—asthma	0.000415	0.00182	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CSF2RB—asthma	0.000411	0.0018	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000407	0.00178	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—BDKRB2—asthma	0.000405	0.00177	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000404	0.00177	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR8—asthma	0.000403	0.00176	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TACR2—asthma	0.000403	0.00176	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL17—asthma	0.000395	0.00173	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PDE4A—asthma	0.000388	0.0017	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—KNG1—asthma	0.000368	0.00161	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—AGTR1—asthma	0.000366	0.0016	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.000364	0.00159	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—GSTT1—asthma	0.000364	0.00159	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CYSLTR1—asthma	0.000363	0.00159	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—POMC—asthma	0.000358	0.00157	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CXCL10—asthma	0.000358	0.00157	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000356	0.00156	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PDE4A—asthma	0.000352	0.00154	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—UTS2—asthma	0.000351	0.00154	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—C5AR1—asthma	0.000351	0.00154	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—VIP—asthma	0.000351	0.00154	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—ADRB2—asthma	0.000347	0.00152	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR4—asthma	0.000336	0.00147	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CYSLTR1—asthma	0.00033	0.00144	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—CXCL8—asthma	0.000328	0.00144	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL2RB—asthma	0.000324	0.00142	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PDE4D—asthma	0.000321	0.0014	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—VIP—asthma	0.000319	0.00139	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—C5AR1—asthma	0.000319	0.00139	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL11—asthma	0.000319	0.00139	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—UTS2—asthma	0.000319	0.00139	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—C3AR1—asthma	0.000314	0.00138	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FCER2—asthma	0.000314	0.00138	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PDE4B—asthma	0.000313	0.00137	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—C5—asthma	0.000313	0.00137	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—TACR1—asthma	0.000313	0.00137	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—EDN1—asthma	0.00031	0.00136	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCL5—asthma	0.000308	0.00135	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR4—asthma	0.000305	0.00134	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CYSLTR2—asthma	0.000302	0.00132	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL2RB—asthma	0.000294	0.00129	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTGDR—asthma	0.000292	0.00128	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LTB4R—asthma	0.000292	0.00128	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL22—asthma	0.000292	0.00128	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PDE4D—asthma	0.000291	0.00128	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR3—asthma	0.000286	0.00125	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000285	0.00125	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PDE4B—asthma	0.000284	0.00124	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TACR1—asthma	0.000284	0.00124	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—C5—asthma	0.000284	0.00124	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—NPY—asthma	0.000279	0.00122	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.000278	0.00122	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCR5—asthma	0.000277	0.00121	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CXCL8—asthma	0.000277	0.00121	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—C3—asthma	0.000271	0.00119	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AGTR2—asthma	0.000269	0.00118	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SERPINA1—asthma	0.000262	0.00115	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR3—asthma	0.00026	0.00114	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—EDNRB—asthma	0.000257	0.00113	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—NPS—asthma	0.000255	0.00112	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—TAC1—asthma	0.000255	0.00112	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—NPY—asthma	0.000253	0.00111	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—GSTP1—asthma	0.000252	0.0011	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCR3—asthma	0.00025	0.00109	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HRH4—asthma	0.000248	0.00109	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PMCH—asthma	0.000248	0.00109	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NPSR1—asthma	0.000248	0.00109	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTGDR2—asthma	0.000248	0.00109	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGTR2—asthma	0.000244	0.00107	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CSF2RB—asthma	0.000243	0.00106	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR8—asthma	0.000238	0.00104	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TACR2—asthma	0.000238	0.00104	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL5—asthma	0.000237	0.00104	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EDNRB—asthma	0.000234	0.00102	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL17—asthma	0.000233	0.00102	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—GSTM1—asthma	0.000232	0.00101	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—NPS—asthma	0.000231	0.00101	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TAC1—asthma	0.000231	0.00101	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—asthma	0.000229	0.001	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—BDKRB2—asthma	0.000229	0.001	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCR3—asthma	0.000227	0.000994	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—ALDH2—asthma	0.000224	0.000979	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—ADCY2—asthma	0.000221	0.000968	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL3—asthma	0.00022	0.000965	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	0.00022	0.000964	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—POMC—asthma	0.000217	0.000949	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL5—asthma	0.000215	0.000942	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GSTT1—asthma	0.000213	0.000931	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCL2—asthma	0.000212	0.000928	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—KIF3A—asthma	0.000208	0.000911	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PDE4A—asthma	0.000208	0.000911	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—KNG1—asthma	0.000208	0.000911	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—BDKRB2—asthma	0.000208	0.000909	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AGTR1—asthma	0.000207	0.000905	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—asthma	0.000204	0.000894	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—asthma	0.000203	0.00089	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL10—asthma	0.000202	0.000885	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—NQO1—asthma	0.000202	0.000882	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ADCY2—asthma	0.000201	0.000879	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL3—asthma	0.0002	0.000876	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—ADRB2—asthma	0.000196	0.000859	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CYSLTR1—asthma	0.000195	0.000853	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—KNG1—asthma	0.000189	0.000827	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CMA1—asthma	0.000188	0.000824	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—UTS2—asthma	0.000188	0.000824	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—C5AR1—asthma	0.000188	0.000824	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL11—asthma	0.000188	0.000824	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VIP—asthma	0.000188	0.000824	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGTR1—asthma	0.000188	0.000822	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—ITPR1—asthma	0.000186	0.000812	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL10—asthma	0.000183	0.000803	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR4—asthma	0.00018	0.00079	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ADRB2—asthma	0.000178	0.00078	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—STAT6—asthma	0.000177	0.000775	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—EDN1—asthma	0.000175	0.000767	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCL5—asthma	0.000174	0.000761	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL2RB—asthma	0.000174	0.00076	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PDE4D—asthma	0.000172	0.000753	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CSF2—asthma	0.000171	0.00075	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ITPR1—asthma	0.000168	0.000738	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GSTP1—asthma	0.000168	0.000736	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—C5—asthma	0.000168	0.000734	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PDE4B—asthma	0.000168	0.000734	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TACR1—asthma	0.000168	0.000734	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CXCL8—asthma	0.000168	0.000734	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—HMOX1—asthma	0.000166	0.000726	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EDN1—asthma	0.000159	0.000697	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—asthma	0.000159	0.000694	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL5—asthma	0.000158	0.000691	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PLA2G4A—asthma	0.000157	0.000689	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR5—asthma	0.000157	0.000686	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CSF2—asthma	0.000156	0.000681	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—asthma	0.000156	0.000681	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GSTM1—asthma	0.000154	0.000676	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL2RA—asthma	0.000154	0.000676	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR3—asthma	0.000153	0.000672	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—C3—asthma	0.000153	0.00067	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NPY—asthma	0.000149	0.000654	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—AGER—asthma	0.000149	0.000652	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—asthma	0.000148	0.000648	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GSTP1—asthma	0.000147	0.000645	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—GSTP1—asthma	0.000145	0.000637	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PPP2CA—asthma	0.000145	0.000634	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGTR2—asthma	0.000144	0.000631	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR5—asthma	0.000142	0.000623	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL2RA—asthma	0.00014	0.000614	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—C3—asthma	0.000139	0.000609	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EDNRB—asthma	0.000138	0.000605	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TAC1—asthma	0.000137	0.000599	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NPS—asthma	0.000137	0.000599	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GSTM1—asthma	0.000135	0.000593	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCR3—asthma	0.000134	0.000587	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—GSTM1—asthma	0.000134	0.000585	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—PDGFB—asthma	0.000133	0.000582	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CYBA—asthma	0.00013	0.000569	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PARP1—asthma	0.000127	0.000556	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL5—asthma	0.000127	0.000556	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BDKRB2—asthma	0.000123	0.000537	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—POMC—asthma	0.000122	0.000536	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADCY2—asthma	0.000119	0.00052	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL3—asthma	0.000118	0.000518	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—KNG1—asthma	0.000112	0.000488	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—POMC—asthma	0.000111	0.000487	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGTR1—asthma	0.000111	0.000486	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL2—asthma	0.000109	0.000476	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6R—asthma	0.000108	0.000475	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL10—asthma	0.000108	0.000474	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—RHOA—asthma	0.000108	0.000472	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NTRK1—asthma	0.000106	0.000466	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRB2—asthma	0.000105	0.000461	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ITPR1—asthma	9.95e-05	0.000436	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—RHOA—asthma	9.8e-05	0.000429	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—POMC—asthma	9.58e-05	0.000419	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CD86—asthma	9.48e-05	0.000415	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL8—asthma	9.47e-05	0.000415	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EDN1—asthma	9.4e-05	0.000412	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL5—asthma	9.33e-05	0.000408	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLA2G4A—asthma	9.29e-05	0.000407	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CSF2—asthma	9.19e-05	0.000402	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL2—asthma	9.05e-05	0.000396	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LTC4S—asthma	9.03e-05	0.000395	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SMAD3—asthma	8.95e-05	0.000392	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL8—asthma	8.6e-05	0.000377	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PPP2CA—asthma	8.56e-05	0.000375	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR5—asthma	8.41e-05	0.000368	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL2RA—asthma	8.28e-05	0.000363	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL2—asthma	8.22e-05	0.00036	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—C3—asthma	8.21e-05	0.00036	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PDGFB—asthma	7.99e-05	0.00035	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LTA4H—asthma	7.83e-05	0.000343	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LEP—asthma	7.65e-05	0.000335	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FN1—asthma	7.21e-05	0.000316	CbGpPWpGaD
Raltegravir—Myocardial infarction—Prednisone—asthma	7.01e-05	0.000214	CcSEcCtD
Raltegravir—Neuropathy peripheral—Prednisone—asthma	7.01e-05	0.000214	CcSEcCtD
Raltegravir—Dizziness—Budesonide—asthma	7.01e-05	0.000214	CcSEcCtD
Raltegravir—Ill-defined disorder—Hydrocortisone—asthma	6.97e-05	0.000212	CcSEcCtD
Raltegravir—Vomiting—Salbutamol—asthma	6.96e-05	0.000212	CcSEcCtD
Raltegravir—Malaise—Prednisolone—asthma	6.93e-05	0.000211	CcSEcCtD
Raltegravir—Dysgeusia—Triamcinolone—asthma	6.92e-05	0.000211	CcSEcCtD
Raltegravir—Vertigo—Prednisolone—asthma	6.91e-05	0.00021	CcSEcCtD
Raltegravir—Rash—Salbutamol—asthma	6.9e-05	0.00021	CcSEcCtD
Raltegravir—Dermatitis—Salbutamol—asthma	6.89e-05	0.00021	CcSEcCtD
Raltegravir—Eye disorder—Betamethasone—asthma	6.89e-05	0.00021	CcSEcCtD
Raltegravir—Eye disorder—Dexamethasone—asthma	6.89e-05	0.00021	CcSEcCtD
Raltegravir—Nausea—Arformoterol—asthma	6.88e-05	0.00021	CcSEcCtD
Raltegravir—Nausea—Formoterol—asthma	6.88e-05	0.00021	CcSEcCtD
Raltegravir—Headache—Salbutamol—asthma	6.85e-05	0.000209	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ARG1—asthma	6.84e-05	0.0003	CbGpPWpGaD
Raltegravir—Back pain—Triamcinolone—asthma	6.84e-05	0.000208	CcSEcCtD
Raltegravir—Malaise—Hydrocortisone—asthma	6.77e-05	0.000206	CcSEcCtD
Raltegravir—Vertigo—Hydrocortisone—asthma	6.75e-05	0.000206	CcSEcCtD
Raltegravir—Nausea—Montelukast—asthma	6.74e-05	0.000205	CcSEcCtD
Raltegravir—Vomiting—Budesonide—asthma	6.74e-05	0.000205	CcSEcCtD
Raltegravir—Angiopathy—Dexamethasone—asthma	6.69e-05	0.000204	CcSEcCtD
Raltegravir—Angiopathy—Betamethasone—asthma	6.69e-05	0.000204	CcSEcCtD
Raltegravir—Rash—Budesonide—asthma	6.68e-05	0.000204	CcSEcCtD
Raltegravir—Dermatitis—Budesonide—asthma	6.68e-05	0.000203	CcSEcCtD
Raltegravir—Headache—Budesonide—asthma	6.64e-05	0.000202	CcSEcCtD
Raltegravir—Hypertension—Prednisolone—asthma	6.64e-05	0.000202	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—POMC—asthma	6.57e-05	0.000288	CbGpPWpGaD
Raltegravir—Ill-defined disorder—Triamcinolone—asthma	6.56e-05	0.0002	CcSEcCtD
Raltegravir—Ill-defined disorder—Methylprednisolone—asthma	6.55e-05	0.000199	CcSEcCtD
Raltegravir—Alopecia—Betamethasone—asthma	6.51e-05	0.000198	CcSEcCtD
Raltegravir—Alopecia—Dexamethasone—asthma	6.51e-05	0.000198	CcSEcCtD
Raltegravir—Nausea—Salbutamol—asthma	6.5e-05	0.000198	CcSEcCtD
Raltegravir—Hypertension—Hydrocortisone—asthma	6.48e-05	0.000198	CcSEcCtD
Raltegravir—Discomfort—Prednisolone—asthma	6.47e-05	0.000197	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCL2—asthma	6.43e-05	0.000281	CbGpPWpGaD
Raltegravir—Erythema—Dexamethasone—asthma	6.42e-05	0.000195	CcSEcCtD
Raltegravir—Erythema—Betamethasone—asthma	6.42e-05	0.000195	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IL6R—asthma	6.41e-05	0.000281	CbGpPWpGaD
Raltegravir—Myalgia—Hydrocortisone—asthma	6.39e-05	0.000195	CcSEcCtD
Raltegravir—Hallucination—Prednisone—asthma	6.39e-05	0.000195	CcSEcCtD
Raltegravir—Malaise—Triamcinolone—asthma	6.38e-05	0.000194	CcSEcCtD
Raltegravir—Anxiety—Hydrocortisone—asthma	6.37e-05	0.000194	CcSEcCtD
Raltegravir—Malaise—Methylprednisolone—asthma	6.36e-05	0.000194	CcSEcCtD
Raltegravir—Vertigo—Triamcinolone—asthma	6.35e-05	0.000194	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.35e-05	0.000193	CcSEcCtD
Raltegravir—Vertigo—Methylprednisolone—asthma	6.34e-05	0.000193	CcSEcCtD
Raltegravir—Discomfort—Hydrocortisone—asthma	6.32e-05	0.000192	CcSEcCtD
Raltegravir—Connective tissue disorder—Prednisone—asthma	6.31e-05	0.000192	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—asthma	6.3e-05	0.000276	CbGpPWpGaD
Raltegravir—Nausea—Budesonide—asthma	6.29e-05	0.000192	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—EGFR—asthma	6.29e-05	0.000275	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALDH7A1—asthma	6.19e-05	0.000271	CbGpPWpGaD
Raltegravir—Cough—Triamcinolone—asthma	6.17e-05	0.000188	CcSEcCtD
Raltegravir—Hypertension—Triamcinolone—asthma	6.1e-05	0.000186	CcSEcCtD
Raltegravir—Hypertension—Methylprednisolone—asthma	6.09e-05	0.000186	CcSEcCtD
Raltegravir—Infection—Hydrocortisone—asthma	6.09e-05	0.000186	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisolone—asthma	6.07e-05	0.000185	CcSEcCtD
Raltegravir—Myalgia—Triamcinolone—asthma	6.02e-05	0.000183	CcSEcCtD
Raltegravir—Nervous system disorder—Hydrocortisone—asthma	6.01e-05	0.000183	CcSEcCtD
Raltegravir—Arthralgia—Methylprednisolone—asthma	6.01e-05	0.000183	CcSEcCtD
Raltegravir—Myalgia—Methylprednisolone—asthma	6.01e-05	0.000183	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—SERPINE1—asthma	6e-05	0.000263	CbGpPWpGaD
Raltegravir—Eye disorder—Prednisone—asthma	6e-05	0.000183	CcSEcCtD
Raltegravir—Anxiety—Methylprednisolone—asthma	5.99e-05	0.000182	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.96e-05	0.000182	CcSEcCtD
Raltegravir—Skin disorder—Hydrocortisone—asthma	5.95e-05	0.000181	CcSEcCtD
Raltegravir—Ill-defined disorder—Betamethasone—asthma	5.95e-05	0.000181	CcSEcCtD
Raltegravir—Ill-defined disorder—Dexamethasone—asthma	5.95e-05	0.000181	CcSEcCtD
Raltegravir—Discomfort—Triamcinolone—asthma	5.95e-05	0.000181	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ARG2—asthma	5.93e-05	0.00026	CbGpPWpGaD
Raltegravir—Discomfort—Methylprednisolone—asthma	5.93e-05	0.000181	CcSEcCtD
Raltegravir—Hyperhidrosis—Hydrocortisone—asthma	5.92e-05	0.000181	CcSEcCtD
Raltegravir—Dry mouth—Triamcinolone—asthma	5.89e-05	0.000179	CcSEcCtD
Raltegravir—Angiopathy—Prednisone—asthma	5.82e-05	0.000177	CcSEcCtD
Raltegravir—Confusional state—Methylprednisolone—asthma	5.81e-05	0.000177	CcSEcCtD
Raltegravir—Immune system disorder—Prednisone—asthma	5.8e-05	0.000177	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—RHOA—asthma	5.79e-05	0.000253	CbGpPWpGaD
Raltegravir—Malaise—Betamethasone—asthma	5.79e-05	0.000176	CcSEcCtD
Raltegravir—Malaise—Dexamethasone—asthma	5.79e-05	0.000176	CcSEcCtD
Raltegravir—Vertigo—Dexamethasone—asthma	5.76e-05	0.000176	CcSEcCtD
Raltegravir—Vertigo—Betamethasone—asthma	5.76e-05	0.000176	CcSEcCtD
Raltegravir—Infection—Triamcinolone—asthma	5.73e-05	0.000175	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NOS3—asthma	5.73e-05	0.000251	CbGpPWpGaD
Raltegravir—Infection—Methylprednisolone—asthma	5.72e-05	0.000174	CcSEcCtD
Raltegravir—Insomnia—Prednisolone—asthma	5.68e-05	0.000173	CcSEcCtD
Raltegravir—Alopecia—Prednisone—asthma	5.67e-05	0.000173	CcSEcCtD
Raltegravir—Nervous system disorder—Methylprednisolone—asthma	5.65e-05	0.000172	CcSEcCtD
Raltegravir—Paraesthesia—Prednisolone—asthma	5.63e-05	0.000172	CcSEcCtD
Raltegravir—Mental disorder—Prednisone—asthma	5.62e-05	0.000171	CcSEcCtD
Raltegravir—Skin disorder—Methylprednisolone—asthma	5.59e-05	0.00017	CcSEcCtD
Raltegravir—Malnutrition—Prednisone—asthma	5.59e-05	0.00017	CcSEcCtD
Raltegravir—Erythema—Prednisone—asthma	5.59e-05	0.00017	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Hydrocortisone—asthma	5.58e-05	0.00017	CcSEcCtD
Raltegravir—Hyperhidrosis—Triamcinolone—asthma	5.58e-05	0.00017	CcSEcCtD
Raltegravir—Hyperhidrosis—Methylprednisolone—asthma	5.57e-05	0.00017	CcSEcCtD
Raltegravir—Insomnia—Hydrocortisone—asthma	5.54e-05	0.000169	CcSEcCtD
Raltegravir—Hypertension—Dexamethasone—asthma	5.54e-05	0.000169	CcSEcCtD
Raltegravir—Hypertension—Betamethasone—asthma	5.54e-05	0.000169	CcSEcCtD
Raltegravir—Paraesthesia—Hydrocortisone—asthma	5.5e-05	0.000168	CcSEcCtD
Raltegravir—Myalgia—Betamethasone—asthma	5.46e-05	0.000166	CcSEcCtD
Raltegravir—Myalgia—Dexamethasone—asthma	5.46e-05	0.000166	CcSEcCtD
Raltegravir—Anxiety—Betamethasone—asthma	5.44e-05	0.000166	CcSEcCtD
Raltegravir—Anxiety—Dexamethasone—asthma	5.44e-05	0.000166	CcSEcCtD
Raltegravir—Discomfort—Dexamethasone—asthma	5.4e-05	0.000164	CcSEcCtD
Raltegravir—Discomfort—Betamethasone—asthma	5.4e-05	0.000164	CcSEcCtD
Raltegravir—Dyspepsia—Hydrocortisone—asthma	5.39e-05	0.000164	CcSEcCtD
Raltegravir—Pain—Prednisolone—asthma	5.37e-05	0.000164	CcSEcCtD
Raltegravir—Decreased appetite—Hydrocortisone—asthma	5.33e-05	0.000162	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Hydrocortisone—asthma	5.29e-05	0.000161	CcSEcCtD
Raltegravir—Fatigue—Hydrocortisone—asthma	5.28e-05	0.000161	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Triamcinolone—asthma	5.26e-05	0.00016	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methylprednisolone—asthma	5.25e-05	0.00016	CcSEcCtD
Raltegravir—Pain—Hydrocortisone—asthma	5.24e-05	0.00016	CcSEcCtD
Raltegravir—Insomnia—Triamcinolone—asthma	5.22e-05	0.000159	CcSEcCtD
Raltegravir—Insomnia—Methylprednisolone—asthma	5.21e-05	0.000159	CcSEcCtD
Raltegravir—Infection—Dexamethasone—asthma	5.2e-05	0.000159	CcSEcCtD
Raltegravir—Infection—Betamethasone—asthma	5.2e-05	0.000159	CcSEcCtD
Raltegravir—Ill-defined disorder—Prednisone—asthma	5.18e-05	0.000158	CcSEcCtD
Raltegravir—Paraesthesia—Triamcinolone—asthma	5.18e-05	0.000158	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisolone—asthma	5.17e-05	0.000158	CcSEcCtD
Raltegravir—Paraesthesia—Methylprednisolone—asthma	5.17e-05	0.000158	CcSEcCtD
Raltegravir—Anaemia—Prednisone—asthma	5.16e-05	0.000157	CcSEcCtD
Raltegravir—Nervous system disorder—Dexamethasone—asthma	5.13e-05	0.000156	CcSEcCtD
Raltegravir—Nervous system disorder—Betamethasone—asthma	5.13e-05	0.000156	CcSEcCtD
Raltegravir—Agitation—Prednisone—asthma	5.13e-05	0.000156	CcSEcCtD
Raltegravir—Thrombocytopenia—Dexamethasone—asthma	5.13e-05	0.000156	CcSEcCtD
Raltegravir—Thrombocytopenia—Betamethasone—asthma	5.13e-05	0.000156	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CXCL8—asthma	5.08e-05	0.000222	CbGpPWpGaD
Raltegravir—Dyspepsia—Triamcinolone—asthma	5.08e-05	0.000155	CcSEcCtD
Raltegravir—Dyspepsia—Methylprednisolone—asthma	5.07e-05	0.000154	CcSEcCtD
Raltegravir—Hyperhidrosis—Dexamethasone—asthma	5.06e-05	0.000154	CcSEcCtD
Raltegravir—Hyperhidrosis—Betamethasone—asthma	5.06e-05	0.000154	CcSEcCtD
Raltegravir—Feeling abnormal—Hydrocortisone—asthma	5.05e-05	0.000154	CcSEcCtD
Raltegravir—Malaise—Prednisone—asthma	5.04e-05	0.000154	CcSEcCtD
Raltegravir—Vertigo—Prednisone—asthma	5.02e-05	0.000153	CcSEcCtD
Raltegravir—Gastrointestinal pain—Hydrocortisone—asthma	5.01e-05	0.000153	CcSEcCtD
Raltegravir—Urticaria—Prednisolone—asthma	4.98e-05	0.000152	CcSEcCtD
Raltegravir—Fatigue—Triamcinolone—asthma	4.97e-05	0.000152	CcSEcCtD
Raltegravir—Fatigue—Methylprednisolone—asthma	4.96e-05	0.000151	CcSEcCtD
Raltegravir—Pain—Triamcinolone—asthma	4.93e-05	0.00015	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ALOX15—asthma	4.92e-05	0.000215	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALOX5AP—asthma	4.92e-05	0.000215	CbGpPWpGaD
Raltegravir—Urticaria—Hydrocortisone—asthma	4.87e-05	0.000148	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IL2—asthma	4.86e-05	0.000213	CbGpPWpGaD
Raltegravir—Body temperature increased—Hydrocortisone—asthma	4.84e-05	0.000148	CcSEcCtD
Raltegravir—Abdominal pain—Hydrocortisone—asthma	4.84e-05	0.000148	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—IL6—asthma	4.83e-05	0.000212	CbGpPWpGaD
Raltegravir—Hypertension—Prednisone—asthma	4.82e-05	0.000147	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Betamethasone—asthma	4.77e-05	0.000145	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Dexamethasone—asthma	4.77e-05	0.000145	CcSEcCtD
Raltegravir—Myalgia—Prednisone—asthma	4.76e-05	0.000145	CcSEcCtD
Raltegravir—Arthralgia—Prednisone—asthma	4.76e-05	0.000145	CcSEcCtD
Raltegravir—Feeling abnormal—Triamcinolone—asthma	4.76e-05	0.000145	CcSEcCtD
Raltegravir—Feeling abnormal—Methylprednisolone—asthma	4.74e-05	0.000145	CcSEcCtD
Raltegravir—Anxiety—Prednisone—asthma	4.74e-05	0.000144	CcSEcCtD
Raltegravir—Insomnia—Dexamethasone—asthma	4.74e-05	0.000144	CcSEcCtD
Raltegravir—Insomnia—Betamethasone—asthma	4.74e-05	0.000144	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.72e-05	0.000144	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methylprednisolone—asthma	4.71e-05	0.000143	CcSEcCtD
Raltegravir—Paraesthesia—Dexamethasone—asthma	4.7e-05	0.000143	CcSEcCtD
Raltegravir—Paraesthesia—Betamethasone—asthma	4.7e-05	0.000143	CcSEcCtD
Raltegravir—Discomfort—Prednisone—asthma	4.7e-05	0.000143	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—CHAT—asthma	4.69e-05	0.000205	CbGpPWpGaD
Raltegravir—Hypersensitivity—Prednisolone—asthma	4.62e-05	0.000141	CcSEcCtD
Raltegravir—Dyspepsia—Betamethasone—asthma	4.61e-05	0.00014	CcSEcCtD
Raltegravir—Dyspepsia—Dexamethasone—asthma	4.61e-05	0.00014	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—MMP9—asthma	4.6e-05	0.000201	CbGpPWpGaD
Raltegravir—Urticaria—Triamcinolone—asthma	4.58e-05	0.00014	CcSEcCtD
Raltegravir—Urticaria—Methylprednisolone—asthma	4.57e-05	0.000139	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PTEN—asthma	4.57e-05	0.0002	CbGpPWpGaD
Raltegravir—Body temperature increased—Triamcinolone—asthma	4.56e-05	0.000139	CcSEcCtD
Raltegravir—Abdominal pain—Methylprednisolone—asthma	4.55e-05	0.000139	CcSEcCtD
Raltegravir—Decreased appetite—Betamethasone—asthma	4.55e-05	0.000139	CcSEcCtD
Raltegravir—Decreased appetite—Dexamethasone—asthma	4.55e-05	0.000139	CcSEcCtD
Raltegravir—Infection—Prednisone—asthma	4.53e-05	0.000138	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Betamethasone—asthma	4.52e-05	0.000138	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Dexamethasone—asthma	4.52e-05	0.000138	CcSEcCtD
Raltegravir—Hypersensitivity—Hydrocortisone—asthma	4.52e-05	0.000138	CcSEcCtD
Raltegravir—Fatigue—Dexamethasone—asthma	4.51e-05	0.000138	CcSEcCtD
Raltegravir—Fatigue—Betamethasone—asthma	4.51e-05	0.000138	CcSEcCtD
Raltegravir—Pain—Betamethasone—asthma	4.48e-05	0.000136	CcSEcCtD
Raltegravir—Pain—Dexamethasone—asthma	4.48e-05	0.000136	CcSEcCtD
Raltegravir—Nervous system disorder—Prednisone—asthma	4.47e-05	0.000136	CcSEcCtD
Raltegravir—Skin disorder—Prednisone—asthma	4.43e-05	0.000135	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisone—asthma	4.41e-05	0.000134	CcSEcCtD
Raltegravir—Asthenia—Hydrocortisone—asthma	4.4e-05	0.000134	CcSEcCtD
Raltegravir—Pruritus—Hydrocortisone—asthma	4.34e-05	0.000132	CcSEcCtD
Raltegravir—Feeling abnormal—Betamethasone—asthma	4.31e-05	0.000131	CcSEcCtD
Raltegravir—Feeling abnormal—Dexamethasone—asthma	4.31e-05	0.000131	CcSEcCtD
Raltegravir—Gastrointestinal pain—Betamethasone—asthma	4.28e-05	0.00013	CcSEcCtD
Raltegravir—Gastrointestinal pain—Dexamethasone—asthma	4.28e-05	0.00013	CcSEcCtD
Raltegravir—Hypersensitivity—Triamcinolone—asthma	4.25e-05	0.00013	CcSEcCtD
Raltegravir—Hypersensitivity—Methylprednisolone—asthma	4.24e-05	0.000129	CcSEcCtD
Raltegravir—Diarrhoea—Hydrocortisone—asthma	4.19e-05	0.000128	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ALOX5—asthma	4.18e-05	0.000183	CbGpPWpGaD
Raltegravir—Urticaria—Dexamethasone—asthma	4.16e-05	0.000127	CcSEcCtD
Raltegravir—Urticaria—Betamethasone—asthma	4.16e-05	0.000127	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Prednisone—asthma	4.15e-05	0.000127	CcSEcCtD
Raltegravir—Dizziness—Prednisolone—asthma	4.15e-05	0.000126	CcSEcCtD
Raltegravir—Asthenia—Triamcinolone—asthma	4.14e-05	0.000126	CcSEcCtD
Raltegravir—Body temperature increased—Betamethasone—asthma	4.14e-05	0.000126	CcSEcCtD
Raltegravir—Body temperature increased—Dexamethasone—asthma	4.14e-05	0.000126	CcSEcCtD
Raltegravir—Abdominal pain—Betamethasone—asthma	4.14e-05	0.000126	CcSEcCtD
Raltegravir—Abdominal pain—Dexamethasone—asthma	4.14e-05	0.000126	CcSEcCtD
Raltegravir—Asthenia—Methylprednisolone—asthma	4.13e-05	0.000126	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—VEGFA—asthma	4.13e-05	0.000181	CbGpPWpGaD
Raltegravir—Insomnia—Prednisone—asthma	4.12e-05	0.000126	CcSEcCtD
Raltegravir—Paraesthesia—Prednisone—asthma	4.09e-05	0.000125	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—STAT3—asthma	4.09e-05	0.000179	CbGpPWpGaD
Raltegravir—Pruritus—Triamcinolone—asthma	4.08e-05	0.000124	CcSEcCtD
Raltegravir—Pruritus—Methylprednisolone—asthma	4.07e-05	0.000124	CcSEcCtD
Raltegravir—Dizziness—Hydrocortisone—asthma	4.05e-05	0.000123	CcSEcCtD
Raltegravir—Dyspepsia—Prednisone—asthma	4.01e-05	0.000122	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—CARM1—asthma	3.99e-05	0.000175	CbGpPWpGaD
Raltegravir—Decreased appetite—Prednisone—asthma	3.96e-05	0.000121	CcSEcCtD
Raltegravir—Rash—Prednisolone—asthma	3.96e-05	0.000121	CcSEcCtD
Raltegravir—Dermatitis—Prednisolone—asthma	3.95e-05	0.00012	CcSEcCtD
Raltegravir—Diarrhoea—Methylprednisolone—asthma	3.94e-05	0.00012	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—DCN—asthma	3.93e-05	0.000172	CbGpPWpGaD
Raltegravir—Fatigue—Prednisone—asthma	3.93e-05	0.00012	CcSEcCtD
Raltegravir—Headache—Prednisolone—asthma	3.93e-05	0.00012	CcSEcCtD
Raltegravir—Constipation—Prednisone—asthma	3.9e-05	0.000119	CcSEcCtD
Raltegravir—Vomiting—Hydrocortisone—asthma	3.9e-05	0.000119	CcSEcCtD
Raltegravir—Rash—Hydrocortisone—asthma	3.86e-05	0.000118	CcSEcCtD
Raltegravir—Dermatitis—Hydrocortisone—asthma	3.86e-05	0.000118	CcSEcCtD
Raltegravir—Headache—Hydrocortisone—asthma	3.84e-05	0.000117	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ALDH2—asthma	3.82e-05	0.000167	CbGpPWpGaD
Raltegravir—Dizziness—Triamcinolone—asthma	3.82e-05	0.000116	CcSEcCtD
Raltegravir—Dizziness—Methylprednisolone—asthma	3.81e-05	0.000116	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—TGFB1—asthma	3.79e-05	0.000166	CbGpPWpGaD
Raltegravir—Feeling abnormal—Prednisone—asthma	3.76e-05	0.000115	CcSEcCtD
Raltegravir—Asthenia—Dexamethasone—asthma	3.76e-05	0.000114	CcSEcCtD
Raltegravir—Asthenia—Betamethasone—asthma	3.76e-05	0.000114	CcSEcCtD
Raltegravir—Gastrointestinal pain—Prednisone—asthma	3.73e-05	0.000114	CcSEcCtD
Raltegravir—Nausea—Prednisolone—asthma	3.73e-05	0.000114	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—EGFR—asthma	3.71e-05	0.000163	CbGpPWpGaD
Raltegravir—Pruritus—Dexamethasone—asthma	3.7e-05	0.000113	CcSEcCtD
Raltegravir—Pruritus—Betamethasone—asthma	3.7e-05	0.000113	CcSEcCtD
Raltegravir—Vomiting—Triamcinolone—asthma	3.67e-05	0.000112	CcSEcCtD
Raltegravir—Vomiting—Methylprednisolone—asthma	3.66e-05	0.000112	CcSEcCtD
Raltegravir—Nausea—Hydrocortisone—asthma	3.64e-05	0.000111	CcSEcCtD
Raltegravir—Rash—Triamcinolone—asthma	3.64e-05	0.000111	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GSTT1—asthma	3.64e-05	0.000159	CbGpPWpGaD
Raltegravir—Dermatitis—Triamcinolone—asthma	3.63e-05	0.000111	CcSEcCtD
Raltegravir—Rash—Methylprednisolone—asthma	3.63e-05	0.000111	CcSEcCtD
Raltegravir—Dermatitis—Methylprednisolone—asthma	3.63e-05	0.000111	CcSEcCtD
Raltegravir—Urticaria—Prednisone—asthma	3.62e-05	0.00011	CcSEcCtD
Raltegravir—Headache—Triamcinolone—asthma	3.61e-05	0.00011	CcSEcCtD
Raltegravir—Headache—Methylprednisolone—asthma	3.61e-05	0.00011	CcSEcCtD
Raltegravir—Body temperature increased—Prednisone—asthma	3.6e-05	0.00011	CcSEcCtD
Raltegravir—Abdominal pain—Prednisone—asthma	3.6e-05	0.00011	CcSEcCtD
Raltegravir—Diarrhoea—Dexamethasone—asthma	3.58e-05	0.000109	CcSEcCtD
Raltegravir—Diarrhoea—Betamethasone—asthma	3.58e-05	0.000109	CcSEcCtD
Raltegravir—Dizziness—Dexamethasone—asthma	3.46e-05	0.000106	CcSEcCtD
Raltegravir—Dizziness—Betamethasone—asthma	3.46e-05	0.000106	CcSEcCtD
Raltegravir—Nausea—Triamcinolone—asthma	3.43e-05	0.000104	CcSEcCtD
Raltegravir—Nausea—Methylprednisolone—asthma	3.42e-05	0.000104	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisone—asthma	3.36e-05	0.000102	CcSEcCtD
Raltegravir—Vomiting—Dexamethasone—asthma	3.33e-05	0.000101	CcSEcCtD
Raltegravir—Vomiting—Betamethasone—asthma	3.33e-05	0.000101	CcSEcCtD
Raltegravir—Rash—Betamethasone—asthma	3.3e-05	0.000101	CcSEcCtD
Raltegravir—Rash—Dexamethasone—asthma	3.3e-05	0.000101	CcSEcCtD
Raltegravir—Dermatitis—Betamethasone—asthma	3.3e-05	0.000101	CcSEcCtD
Raltegravir—Dermatitis—Dexamethasone—asthma	3.3e-05	0.000101	CcSEcCtD
Raltegravir—Headache—Dexamethasone—asthma	3.28e-05	0.0001	CcSEcCtD
Raltegravir—Headache—Betamethasone—asthma	3.28e-05	0.0001	CcSEcCtD
Raltegravir—Asthenia—Prednisone—asthma	3.27e-05	9.97e-05	CcSEcCtD
Raltegravir—Pruritus—Prednisone—asthma	3.23e-05	9.83e-05	CcSEcCtD
Raltegravir—Diarrhoea—Prednisone—asthma	3.12e-05	9.51e-05	CcSEcCtD
Raltegravir—Nausea—Betamethasone—asthma	3.11e-05	9.48e-05	CcSEcCtD
Raltegravir—Nausea—Dexamethasone—asthma	3.11e-05	9.48e-05	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—NQO1—asthma	3.02e-05	0.000132	CbGpPWpGaD
Raltegravir—Dizziness—Prednisone—asthma	3.02e-05	9.19e-05	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ADCY2—asthma	2.96e-05	0.00013	CbGpPWpGaD
Raltegravir—Vomiting—Prednisone—asthma	2.9e-05	8.83e-05	CcSEcCtD
Raltegravir—Rash—Prednisone—asthma	2.87e-05	8.76e-05	CcSEcCtD
Raltegravir—Dermatitis—Prednisone—asthma	2.87e-05	8.75e-05	CcSEcCtD
Raltegravir—Headache—Prednisone—asthma	2.86e-05	8.7e-05	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IL6—asthma	2.85e-05	0.000125	CbGpPWpGaD
Raltegravir—Nausea—Prednisone—asthma	2.71e-05	8.25e-05	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GSTP1—asthma	2.52e-05	0.00011	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMOX1—asthma	2.49e-05	0.000109	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ITPR1—asthma	2.48e-05	0.000109	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CAT—asthma	2.45e-05	0.000107	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GSTM1—asthma	2.32e-05	0.000101	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLA2G4A—asthma	2.32e-05	0.000101	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPP2CA—asthma	2.13e-05	9.34e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—asthma	1.64e-05	7.17e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—asthma	1.49e-05	6.54e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NOS3—asthma	1.43e-05	6.25e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—asthma	1.31e-05	5.72e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTEN—asthma	1.14e-05	4.99e-05	CbGpPWpGaD
